591 related articles for article (PubMed ID: 20303944)
1. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
Bhalla S; Zhang Z; Patterson N; Gulati A
Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
[TBL] [Abstract][Full Text] [Related]
2. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
4. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874.
Bhalla S; Rapolaviciute V; Gulati A
Eur J Pharmacol; 2011 Jan; 651(1-3):109-21. PubMed ID: 21114998
[TBL] [Abstract][Full Text] [Related]
5. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
Andurkar SV; Gendler L; Gulati A
Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
[TBL] [Abstract][Full Text] [Related]
6. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
7. Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells.
Bhalla S; Ciaccio N; Wang ZJ; Gulati A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1152-6. PubMed ID: 16741067
[TBL] [Abstract][Full Text] [Related]
8. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
9. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of oxycodone antinociception in mice by agmatine and BMS182874 via an imidazoline I2 receptor-mediated mechanism.
Bhalla S; Ali I; Lee H; Andurkar SV; Gulati A
Pharmacol Biochem Behav; 2013 Jan; 103(3):550-60. PubMed ID: 23103903
[TBL] [Abstract][Full Text] [Related]
11. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
14. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
15. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
16. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Kest B; McLemore G; Kao B; Inturrisi CE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
[TBL] [Abstract][Full Text] [Related]
17. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the antinociceptive effect of oxycodone in male and female rats.
Holtman JR; Wala EP
Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
[TBL] [Abstract][Full Text] [Related]
19. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
20. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]